Hims & Hers Health Inc. (HIMS) saw its stock price soar by 5.20% during intraday trading on Wednesday.
The surge followed the company's disclosure that board member David Wells purchased 48,400 shares on May 26, a move that boosted investor confidence. Wells, a financial veteran and former Netflix CFO, increased his total stake in the telehealth firm to 224,417 shares.
The insider buying activity comes as Hims & Hers stock has faced significant pressure over the past year, declining 66% from its 52-week high due to challenges including an FDA crackdown on compounded weight-loss drugs, a patent lawsuit, and a miss in quarterly results.
Comments